Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 11/2016

01-11-2016 | Literatur kommentiert

Prä- oder postoperative Strahlentherapie bei retroperitonealen Sarkomen unverzichtbar

Author: Prof. Dr. Jürgen Dunst

Published in: Strahlentherapie und Onkologie | Issue 11/2016

Login to get access

Auszug

Retroperitoneale Sarkome sind eine therapeutische Herausforderung. Die Möglichkeiten der operativen Therapie sind eingeschränkt, und als Folge gibt es hohe Lokalrezidivraten. Allerdings ist auch eine Strahlentherapie in diesen Lokalisationen nicht einfach. Ferner war die Datenlage lange Zeit sehr dünn und unübersichtlich, und die Empfehlungen zur Strahlentherapie sind bisher relativ zurückhaltend formuliert. Eine aktuelle, sehr große Kohortenanalyse belegt aber den hohen Stellenwert der Strahlentherapie und zeigt auch einen signifikanten Überlebensvorteil [9]. …
Literature
1.
2.
Baldini EH, Wang D, Haas RL et al (2015) Treatment guidelines for preoperative radiation therapy for retroperitoneal sarcoma: preliminary consensus of an international expert panel. Int J Radiat Oncol Biol Phys 92:602–612CrossRefPubMed
3.
Baldini EH, Abrams RA, Bosch W et al (2015) Retroperitoneal sarcoma target volume and organ at risk contour delineation agreement among NRG sarcoma radiation oncologist. Int J Radiat Oncol Biol Phys 92:1053–1059CrossRefPubMedPubMedCentral
4.
ESMO / European Sarcoma Network Working Group (2012) Soft tissue and visceral sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Supplement 7):vii92–vii99
5.
Gronchi A, Lo Vullo S, Fiore M et al (2009) Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 27:24–30CrossRefPubMed
6.
Gronchi A, Miceli R, Colombo C et al (2012) Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. Ann Oncol 23:1067–1073CrossRefPubMed
7.
Lane WO, Cramer CK, Nussbaum DP et al (2015) Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma. J Surg Oncol 112:352–358CrossRefPubMed
8.
von Mehren M, Randall R, Benjamin RS et al (2014) Soft tissue sarcoma, version 2. 2014 featured updates to the NCCN Gguidelines. J Natl Compr Canc Netw 12:473–483
9.
Nussbaum DP, Rushing CN, Lane WO et al (2016) Preoperative or postoperative radiotherapy versus surgery alone for retroperitoneal sarcoma: a case-control, propensity score-matched analysis of a nationwide clinical oncology database. Lancet Oncol. doi:10.​1016/​S1470-2045(16)30050-X PubMed
10.
Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY (2010) Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients. J Surg Oncol 101:345–350PubMed
11.
Trans-Atlantic RPSWG (2010) Management of primary retroperitoneal 261 patients. J Surg Oncol 101:345–350
Metadata
Title
Prä- oder postoperative Strahlentherapie bei retroperitonealen Sarkomen unverzichtbar
Author
Prof. Dr. Jürgen Dunst
Publication date
01-11-2016
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 11/2016
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-016-1042-4

Other articles of this Issue 11/2016

Strahlentherapie und Onkologie 11/2016 Go to the issue

Literatur kommentiert

Radikale Zystektomie vs. Radiochemotherapie zur Behandlung des Blasenkarzinoms im Stadium T2–4a N0 M0

Original Article

Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma

Erratum

Erratum to: Hypofractionated radiotherapy for localized prostate cancer

Editorial

Some considerations for future research into the risks of radiation-induced cardiovascular diseases

Original Article

Novel technique for high-precision stereotactic irradiation of mouse brains

Abstracts

2nd Joint Meeting SASRO/SGSMP